Telangana continues to shine on the world stage.
The Hon’ble Minister for Industries and Information Technology, Shri D. Sridhar Babu, has been invited by the Government of Victoria and the Government of Australia to deliver the keynote address at AusBiotech 2025.
This is one of Asia-Pacific’s top life sciences events.
Telangana is the only Indian state invited to this prestigious convention.
This recognition highlights its rise as a leader in biotechnology, pharmaceuticals, and healthcare innovation.
Strengthening Global Ties in Life Sciences
Earlier today, Ms Hilary McGeachy, Consul General of Australia, met Minister Sridhar Babu in Hyderabad.
They discussed Telangana’s participation at the event and explored ways to deepen cooperation in healthcare innovation, artificial intelligence, research, and advanced manufacturing.
This invitation reflects Telangana’s rapid transformation under the leadership of the Hon’ble Chief Minister and Minister Sridhar Babu.
In just two years, the state’s life sciences sector attracted investments of over ₹63,000 crore.
As a result, Telangana now stands as a global hub for biotechnology and medtech innovation.
Telangana: India’s Life Sciences Capital
According to a CBRE report, Hyderabad ranks among the top seven global life sciences clusters.
Notably, it is the only Indian city to make this list.
Moreover, Telangana’s engagement with global partners is growing.
Earlier this year, the Governor of Queensland and the Minister for Finance and Trade of Queensland attended BioAsia 2025 in Hyderabad.
Their visit strengthened the collaboration between Australia and Telangana in research and technology.
In addition, a large Australian delegation will attend BioAsia 2026, continuing this partnership.
About Telangana Life Sciences (TGLS)
Telangana is home to over 2,000 life sciences companies with a combined valuation of $80 billion.
It contributes nearly 40% of India’s pharmaceutical production and one-third of global vaccine output.
Because of this, Hyderabad is known as the “Vaccine Capital of the World.”
The state’s growth stems from strong infrastructure, investor-friendly policies, and a skilled talent base.
Through the Telangana Global Life Sciences (TGLS) platform, it connects global investors, researchers, and policymakers.
This initiative accelerates the goal of building a $250-billion life sciences economy by 2030.
Conclusion
Telangana’s participation in AusBiotech 2025 marks a major milestone for India’s innovation story.
Minister D. Sridhar Babu’s keynote will highlight the state’s success and promote international collaboration with Australia.
As a result, Telangana’s vision for a sustainable, innovation-driven life sciences future grows stronger.
The state continues to lead by example, inspiring the world through its commitment, innovation, and excellence.
